Characteristics and motives of college students who engage in nonmedical use of methylphenidate

American Journal on Addictions

Volumn 17, Issue 3, 2008, Pages 167-171

  DuPont, Robert L ^a   Coleman, John J ^b   Bucher, Richard H ^a   Wilford, Bonnie B ^c  

^a Institute for Behavior and Health   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c JBS International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMETHYLPHENIDATE; METHYLPHENIDATE;

ADULT; ANALYTIC METHOD; ARTICLE; COLLEGE STUDENT; CONTROLLED STUDY; DRUG MISUSE; FAMILY; FEMALE; FRIEND; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; RECREATION;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; METHYLPHENIDATE; MOTIVATION; QUESTIONNAIRES; STUDENTS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 45849150744     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490802019642     Document Type: Article

References (28)

1. Poulton A. Long-term outcomes of stimulant medication in attentiondeficit hyperactivity disorder. Expert Rev Neurother. 2006;6:551-561.
2. Aggregate production quotas. 21 CFR 1303.11; 1970 available online from http://www.gpoaccess.gov/cfr/retrieve.html.
3. Drug Enforcement Administration. Aggregate Production Quota History. 2006 available online from http://www.deadiversion.usdoj.gov/ quotas/quota history.htm.
4. Daley D. Attention deficit hyperactivity disorder: a review of the essential facts. Child Care Health Dev. 2006;32:193-204.
5. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716-723.
6. Substance Abuse and Mental Health Services Administration. The NSDUH Report: Stimulant Use, 2003. 2005 available online from http://www.oas. samhsa.gov/2k5/stimulants/stimulants.pdf. Rockville, MD: Department of Health and Human Services.
7. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Drug Abuse Warning Network, 2005: National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-29, DHHS Publication No. (SMA) 07-4256; 2007 available online from http://dawninfo.samhsa.gov/files/ DAWN-ED-2005-Web.pdf. Rochester, MD: Department of Health and Human Services.
8. Substance Abuse and Mental Health Services Administration. College Enrollment Status and Past Year Illicit Drug Use among Young Adults: 2002, 2003, and 2004. 2005
9. Teter CJ, McCabe SE, Lagrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy. 2006;26: 1501-1510 available online from http://www.oas.samhsa.gov/2k5/college/college.cfm. Rochester, MD: Department of Health and Human Services.
10. Fortson BL, Scotti JR, Del Ben KS, Chen Y-C. Reliability and validity of an Internet traumatic stress survey with a college student sample. J Trauma Stress. 2006;19:709-720.
11. Denscombe M. Web-based questionnaires and the mode effect: an evaluation based on completion rates and data contents of near-identical questionnaires delivered in different modes. Social Science Computer Review. 2006;24:246-254.
12. Harris Interactive, Inc. Harris Interactive [homepage]. Rochester, NY: Harris Interactive, Inc., 2007. http://www.harrisinteractive.com/. Accessed July 28, 2007.
13. Harris Interactive. Harris Poll Online Panel [Web page]. Harris Interactive Web site http://www.harrisinteractive.com/partner/hpolpanel.asp. Accessed July 30, 2007.
14. Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health. 2000;49:143-145.
15. Volkow ND, Swanson JM. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003;160:1909-1918.
16. Morton WA, Stockton GG. Methylphenidate abuse and psychiatric side effects. Primary Care Companion to the Journal of Clinical Psychiatry. 2000;2:159-164.
17. Stoops WW, Glaser PE, Rush CR. Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis. Drug Alcohol Depend. 2003;71:179-186.
18. Ciccone PE, Starr HL, Coleman J, Mrazik T, DuPont RL, Bensinger PB. OROS(r) MPH: a methylphenidate formulation with a low potential for abuse. Annual Meeting, Pediatric Academic Societies. Toronto, Ontario, Canada: Ortho-McNeil Janssen Scientific Affairs, LLC; May 5-8, 2007.
19. Poulin C. Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. CMAJ. 2001;165:1039-1044.
20. Kollins SH, Rush CR, Pazzaglia PJ, Ali JA. Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Exp Clin Psychopharmacol. 1998;6:367-374.
21. Coleman JJ, Bensinger PB, Gold MS, Smith DE, Bianchi RP, DuPont RL. Can drug design inhibit abuse? J Psychoactive Drugs. 2005;37:343-362.
22. Cone EJ. Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet. Drug Alcohol Depend. 2006;83 (Suppl. 1):S31-S39.
23. Mansbach RS, Moore RA. Formulation considerations for the development of medications with abuse potential. Drug Alcohol Depend. 2006;83 (Suppl. 1):S15-S22.
24. Food and Drug Administration. FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Events, FDA News, 21 February 2007, Doc. No. P07-26; available online from http://www.fda.gov/bbs/topics/news/2007/new.1568.html. Rockville, MD: author.
25. Controlled Substances Act. 21 USC 841; 1970.
26. Controlled Substances Act. 21 USC 844; 1970.
27. Controlled Substances Act. 21 USC 843(a)(3); 1970.
28. Harrison AG, Edwards MJ, Parker KC. Identifying students faking ADHD: preliminary findings and strategies for detection. Arch Clin Neuropsychol. 2007;22:577-588.